Cheng Kong Shih
Vorstandsvorsitzender bei Xuanzhu Biopharmaceutical Co., Ltd.
Profil
Cheng Kong Shih is currently the Vice Chairman, Chief Scientist & General Manager at Xuanzhu Biopharmaceutical Co., Ltd.
He started this position in 2021.
Prior to his current role, he obtained a doctorate degree from The Rockefeller University.
Aktive Positionen von Cheng Kong Shih
| Unternehmen | Position | Beginn |
|---|---|---|
Xuanzhu Biopharmaceutical Co., Ltd.
 Xuanzhu Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xuanzhu Biopharmaceutical Co., Ltd. engages in the research and development of chemical and biological drugs. Its products include small molecular chemical drugs, monoclonal antibodies, bispecific antibodies, and antibody conjugated drugs. The company was founded in 2002 and is headquartered in Shijiazhuang, China. | Vorstandsvorsitzender | 01.12.2018 |
Ausbildung von Cheng Kong Shih
| The Rockefeller University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Xuanzhu Biopharmaceutical Co., Ltd.
Xuanzhu Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xuanzhu Biopharmaceutical Co., Ltd. engages in the research and development of chemical and biological drugs. Its products include small molecular chemical drugs, monoclonal antibodies, bispecific antibodies, and antibody conjugated drugs. The company was founded in 2002 and is headquartered in Shijiazhuang, China. | Commercial Services |
